Skip to main content

Nebula Research & Development LLC

SEC CIK
0001792635
Latest filing
May 15, 2026

LYEL holding history

Lyell Immunopharma, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LYEL overviewAll 13F holders of LYELFull Q1 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2023
Holdings of LYEL by Nebula Research & Development LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−12,305−100.0%Sold outHolders
Q2 202312,305$39.1K<0.1%+12,305NewHolders